查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595419

POC 血糖检测市场：按产品、采购类型和最终用户 - 2025-2030 年全球预测

Point-of-Care Glucose Testing Market by Product, Mode of Purchase, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年POC血糖检测市值为67亿美元，预计2024年将达72亿美元，复合年增长率为7.54%，预计2030年将达到111.5亿美元。

POC 血糖测试 (POCT) 的范围包括提供即时血糖浓度读数的重要作用，从而能够在医院、诊所和家庭等各种环境中及时管理糖尿病。 POCT 的需求源自于糖尿病盛行率的增加以及定期监测以预防併发症的需要。 POCT 有广泛的应用，包括糖尿病患者的自我监测、临床和紧急情况下的糖尿病管理，以及在血糖控制很重要的手术和救生过程中。最终用途范围主要包括医院、诊所和居家医疗，由于便利性和患者健康管理能力的增强，家庭检测的趋势日益增长。

主要市场统计
基准年[2023] 67亿美元
预测年份 [2024] 72亿美元
预测年份 [2030] 111.5亿美元
复合年增长率（%） 7.54%

该市场的关键成长要素包括全球糖尿病盛行率上升、非侵入性监测仪等检测设备的技术进步以及医疗保健支出的增加。机会主要存在于医疗基础设施发达、糖尿病人口不断增长的新兴市场，价格实惠且易于使用的 POCT 设备可以产生重大影响。抓住这些机会的建议包括利用技术创新实现产品差异化、强调用户友好的介面以及建立策略伙伴关係以实现市场扩张和分销。

然而，市场成长面临监管挑战、先进测试设备的高成本以及来自连续血糖监测仪等替代技术的竞争等限制。数位 POCT 解决方案中还存在与资料管理相关的隐私问题。具有创新潜力的领域包括开发非侵入性测试方法、整合人工智慧进行预测分析和即时监控，以及提高设备的便携性和连接性。探索这些途径可以提高患者的依从性并导致更广泛的采用。市场的本质是动态但分散的，对于提供颠覆性技术的新进入者来说具有巨大的潜力。重点研究和开发以及对区域市场动态的了解对于该领域的可持续业务成长至关重要。

市场动态：揭示快速发展的 POC 血糖测试市场的关键市场见解

POC 血糖检测市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 糖尿病患者增加
    • 越来越多地将资料管理程序纳入血糖监测中
    • 已开发国家和新兴国家对居家医疗的需求不断增长
  • 市场限制因素
    • 产品开发成本高
  • 市场机会
    • 整合数位技术以实现更好的检查
    • 扩大供应链和分销网络
  • 市场问题
    • 血糖仪的潜在干扰与校准问题

波特五力：驾驭 POC 血糖检测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解POC血糖检测市场的外部影响

外部宏观环境因素在塑造POC血糖检测市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解POC血糖检测市场的竞争格局

对 POC 血糖测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵：POC血糖检测市场厂商绩效评估

FPNV定位矩阵是评估POC血糖检测市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製 POC 血糖检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对 POC 血糖测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 糖尿病盛行率增加
      • 在血糖值监测中更多地采用资料管理程序
      • 已开发国家和新兴国家对居家医疗的需求不断增长
    • 抑制因素
      • 产品开发成本高
    • 机会
      • 整合数位技术以实现更好的测试
      • 扩大供应链和分销网络
    • 任务
      • 血糖值仪的潜在干扰与校准问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 POC 血糖检测市场：分产品

  • 介绍
  • Accu Check Aviva Meter
  • Accu-Chek Inform II
  • 拜耳 Contour 血糖监测系统
  • Freestyle Lite
  • i-STAT
  • Onetouch Verio Flex
  • StatStrip
  • True Metrix

第七章 POC 血糖检测市场：依购买类型

  • 介绍
  • 市售测试产品
  • 处方笺测试产品

第八章 POC 血糖检测市场：依最终用户分类

  • 介绍
  • 居家医疗
  • 医院及重症监护中心
  • 门诊/门诊护理设施

第九章 北美、南美POC血糖检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太POC血糖检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲POC血糖检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AccubIoTech Co. Ltd.
  • ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
  • Bio-Rad Laboratories
  • Danaher Corporation
  • EKF Diagnostics by IBL PLC
  • F. Hoffmann-La Roche Ltd.
  • Fluxergy
  • LifeScan, Inc.
  • Medtronic PLC
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Prodigy Diabetes Care, LLC.
  • Siemens Healthineers AG
  • Sinocare
Product Code: MRR-B9334AD6C44F

The Point-of-Care Glucose Testing Market was valued at USD 6.70 billion in 2023, expected to reach USD 7.20 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 11.15 billion by 2030.

The scope of Point-of-Care Glucose Testing (POCT) encompasses its critical role in providing immediate glucose level readings, enabling timely management of diabetes in various settings such as hospitals, clinics, and home environments. The necessity of POCT arises from the growing prevalence of diabetes and the need for regular monitoring to prevent complications. Its applications span across self-monitoring for individuals with diabetes, diabetes management in clinical and emergency settings, and during surgeries or critical care where glucose control is vital. The end-use scope largely includes hospitals, clinics, and home care, with an increasing trend toward home testing due to convenience and rising patient empowerment in managing health.

KEY MARKET STATISTICS
Base Year [2023] USD 6.70 billion
Estimated Year [2024] USD 7.20 billion
Forecast Year [2030] USD 11.15 billion
CAGR (%) 7.54%

Key growth influencers in the market include the rising incidence of diabetes globally, technological advancements in testing devices such as non-invasive monitors, and increased healthcare spending. Opportunities mainly lie in emerging markets with growing healthcare infrastructure and a rising diabetic population, where affordable and easy-to-use POCT devices can make a significant impact. Recommendations for capturing these opportunities include leveraging technological innovations for product differentiation, focusing on user-friendly interfaces, and forging strategic partnerships for market expansion and distribution.

However, market growth faces limitations like regulatory challenges, high cost of advanced testing devices, and competition from alternative technologies like continuous glucose monitors. There are also privacy concerns related to data management in digital POCT solutions. Areas poised for innovation include the development of non-invasive testing methods, integration of AI for predictive analytics and real-time monitoring, and improvements in device portability and connectivity. Exploring these avenues can lead to enhanced patient compliance and broader adoption. The market's nature is dynamic yet fragmented, with significant potential for new entrants offering disruptive technologies. Focused R&D and an understanding of regional market dynamics are crucial for sustained business growth in this sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point-of-Care Glucose Testing Market

The Point-of-Care Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the prevalence rate of diabetic patients
    • Growing incorporation of data management programs in the monitoring of glucose
    • Growing demand for home healthcare from developed and developing countries
  • Market Restraints
    • High cost of product development
  • Market Opportunities
    • Integration of digital technologies for better testing
    • Expansion of supply chain and distribution networks
  • Market Challenges
    • Potential interference and calibration issues in glucose meters

Porter's Five Forces: A Strategic Tool for Navigating the Point-of-Care Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point-of-Care Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point-of-Care Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point-of-Care Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point-of-Care Glucose Testing Market

A detailed market share analysis in the Point-of-Care Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point-of-Care Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point-of-Care Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point-of-Care Glucose Testing Market

A strategic analysis of the Point-of-Care Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point-of-Care Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio-Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, Prodigy Diabetes Care, LLC., Siemens Healthineers AG, and Sinocare.

Market Segmentation & Coverage

This research report categorizes the Point-of-Care Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, i-STAT, Onetouch Verio Flex, StatStrip, and True Metrix.
  • Based on Mode of Purchase, market is studied across OTC Testing Product and Prescription-Based Testing Product.
  • Based on End-User, market is studied across Home Care Settings, Hospitals & Critical Care Centers, and Outpatient & Ambulatory Care Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the prevalence rate of diabetic patients
      • 5.1.1.2. Growing incorporation of data management programs in the monitoring of glucose
      • 5.1.1.3. Growing demand for home healthcare from developed and developing countries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of product development
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of digital technologies for better testing
      • 5.1.3.2. Expansion of supply chain and distribution networks
    • 5.1.4. Challenges
      • 5.1.4.1. Potential interference and calibration issues in glucose meters
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Point-of-Care Glucose Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Accu Check Aviva Meter
  • 6.3. Accu-Chek Inform II
  • 6.4. Bayer Contour Blood Glucose Monitoring System
  • 6.5. Freestyle Lite
  • 6.6. i-STAT
  • 6.7. Onetouch Verio Flex
  • 6.8. StatStrip
  • 6.9. True Metrix

7. Point-of-Care Glucose Testing Market, by Mode of Purchase

  • 7.1. Introduction
  • 7.2. OTC Testing Product
  • 7.3. Prescription-Based Testing Product

8. Point-of-Care Glucose Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Home Care Settings
  • 8.3. Hospitals & Critical Care Centers
  • 8.4. Outpatient & Ambulatory Care Facilities

9. Americas Point-of-Care Glucose Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Point-of-Care Glucose Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Point-of-Care Glucose Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accubiotech Co. Ltd.
  • 3. ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
  • 4. Bio-Rad Laboratories
  • 5. Danaher Corporation
  • 6. EKF Diagnostics by IBL PLC
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Fluxergy
  • 9. LifeScan, Inc.
  • 10. Medtronic PLC
  • 11. Nipro Corporation
  • 12. Nova Biomedical Corporation
  • 13. Prodigy Diabetes Care, LLC.
  • 14. Siemens Healthineers AG
  • 15. Sinocare

LIST OF FIGURES

  • FIGURE 1. POINT-OF-CARE GLUCOSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023